William Pickering
Stock Analyst at Bernstein
(1.14)
# 3,562
Out of 4,870 analysts
23
Total ratings
40%
Success rate
-9.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Pickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Outperform | $314 → $310 | $313.13 | -1.00% | 2 | Jan 7, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $1,110 → $1,070 | $511.92 | +109.02% | 2 | Jan 7, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Market Perform | $27 → $24 | $15.51 | +54.74% | 2 | Nov 29, 2024 | |
| BHVN Biohaven | Maintains: Outperform | $55 → $66 | $14.46 | +356.43% | 2 | Sep 24, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Outperform | $116 → $90 | $54.08 | +66.42% | 4 | Sep 17, 2024 | |
| IONS Ionis Pharmaceuticals | Upgrades: Market Perform | n/a | $37.72 | - | 2 | Jun 14, 2024 | |
| VRTX Vertex Pharmaceuticals | Downgrades: Market Perform | n/a | $443.54 | - | 5 | Feb 2, 2024 | |
| NTLA Intellia Therapeutics | Initiates: Outperform | $54 | $9.23 | +485.05% | 1 | Mar 21, 2023 | |
| BEAM Beam Therapeutics | Initiates: Market Perform | $37 | $16.71 | +121.42% | 1 | Mar 21, 2023 | |
| ALLO Allogene Therapeutics | Initiates: Market Perform | $6 | $1.22 | +391.80% | 1 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $44 | $45.55 | -3.40% | 1 | Mar 21, 2023 |
Alnylam Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $314 → $310
Current: $313.13
Upside: -1.00%
Regeneron Pharmaceuticals
Jan 7, 2025
Maintains: Outperform
Price Target: $1,110 → $1,070
Current: $511.92
Upside: +109.02%
Arrowhead Pharmaceuticals
Nov 29, 2024
Maintains: Market Perform
Price Target: $27 → $24
Current: $15.51
Upside: +54.74%
Biohaven
Sep 24, 2024
Maintains: Outperform
Price Target: $55 → $66
Current: $14.46
Upside: +356.43%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Outperform
Price Target: $116 → $90
Current: $54.08
Upside: +66.42%
Ionis Pharmaceuticals
Jun 14, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $37.72
Upside: -
Vertex Pharmaceuticals
Feb 2, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $443.54
Upside: -
Intellia Therapeutics
Mar 21, 2023
Initiates: Outperform
Price Target: $54
Current: $9.23
Upside: +485.05%
Beam Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $37
Current: $16.71
Upside: +121.42%
Allogene Therapeutics
Mar 21, 2023
Initiates: Market Perform
Price Target: $6
Current: $1.22
Upside: +391.80%
Mar 21, 2023
Initiates: Market Perform
Price Target: $44
Current: $45.55
Upside: -3.40%